Raymond James analyst Andrew Cooper downgraded Exact Sciences (NASDAQ: EXAS) from Strong Buy to Outperform with a price target of $130.00 (from $160.00).

For an analyst ratings summary and ratings history on Exact Sciences click here. For more ratings news on Exact Sciences click here.

Shares of Exact Sciences closed at $95.63 yesterday.